As of Feb 27
| -1.40 / -4.24%|
The 3 analysts offering 12-month price forecasts for Medifast Inc have a median target of 33.00, with a high estimate of 33.00 and a low estimate of 32.00. The median estimate represents a +4.30% increase from the last price of 31.64.
The current consensus among 3 polled investment analysts is to Hold stock in Medifast Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.